Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them in Africa QIAprep&amp Plasmodium Kit enables streamlined detection of five malaria-causing parasites for epidemiological research and surveillance Novel QIAGEN assays support mixed-infection tracking, vaccine impact assessment and malaria control strategies in regions […]

Limula appoints cell therapy expert, Dr. Jonathan Esensten, to its Strategic Advisory Board. The appointment supports the development of LimONE, Limula’s integrated platform for automated cell and gene therapy (CGT) manufacturing. Lausanne, Switzerland – Limula, an emerging life science tools company specializing in automated Cell and Gene Therapy manufacturing solutions, has appointed Dr. Jonathan Esensten to […]

Mr. Jeffrey Gatz Brings Track Record of Growing companies and expertise in the Life Science Tools spaceg. WEST SACRAMENTO, Calif. — Gemini Bioproducts, LLC (“GeminiBio”), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Jeffrey Gatz to its […]

Simoa® technology highlighted in more than 80 posters and oral presentations demonstrating its impact on neurodegenerative disease research BILLERICA, MA –  Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried blood spot extraction (DBS) kit as part of their industry-leading Simoa® assay kits at the International […]

Following a successful Korea launch, MEPSGEN brings advanced microfluidic technology to U.S. researchers NanoCalibur™ offers precise, scalable, and reproducible nanoparticle production for drug development MEPSGEN’s CEO to present new technology at the 4th LNP Formulation & Process Development Summit, on April 15, in Boston. BOSTON — MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCalibur™, a […]

First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of monoclonal antibody producing cells Cambridge, UK: Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch […]

Collaboration to enable cost-effective end-to-end genotyping across large animal and plant populations Companies to present poster at AGBT-Ag SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich. —  Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics […]

Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb CORALVILLE, Iowa and SAN CARLOS Calif. — Global genomics solutions leader Integrated DNA Technologies (IDT) and Elegen, the leader in next-generation DNA manufacturing, are teaming up to offer IDT customers early access to Elegen’s ENFINIA™ Plasmid DNA, […]

Bethlehem, PA — ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform poised to transform cell expansion for Advanced Therapy Medicinal Products (ATMPs). Designed to overcome the limitations of currently available systems, the ATB™ delivers unprecedented process control and scalability from […]

Tokyo – Hitachi High-Tech Corporation (“Hitachi High-Tech”) is strengthening its analytical business through integrating and jointly operating its Hitachi High-Tech Analytical Science Ltd. (“Hitachi High-Tech Analytical Science”) and Hitachi High-Tech Science Corporation (“Hitachi High-Tech Science”) businesses. As of April 1, 2025, Hitachi High-Tech Science will become Hitachi High-Tech Analysis Corporation as part of this re-structure. By […]